CHEK2 and thyroid gland carcinoma: The cross-sectional study of Leedom et al. reports a statistically significant higher incidence of thyroid cancer history in carriers of truncating CHEK2 variants versus non-carriers, but no conclusions can be drawn for papillary thyroid cancer specifically as no pathological details of thyroid cancer are available [11].